E Fund Management Co. Ltd. Has $279,000 Stock Position in CVS Health Co. (NYSE:CVS)

E Fund Management Co. Ltd. raised its holdings in CVS Health Co. (NYSE:CVS) by 11.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,722 shares of the pharmacy operator’s stock after buying an additional 467 shares during the quarter. E Fund Management Co. Ltd.’s holdings in CVS Health were worth $279,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CVS. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $32,000. First Community Trust NA increased its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the period. Creekmur Asset Management LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $34,000. Steph & Co. increased its position in shares of CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the period. Finally, ORG Partners LLC increased its position in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Up 1.0 %

Shares of CVS opened at $58.42 on Thursday. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The firm has a market capitalization of $73.34 billion, a PE ratio of 10.27, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53. The stock’s fifty day simple moving average is $58.33 and its 200-day simple moving average is $62.74.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, research analysts predict that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.55%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Monday. Royal Bank of Canada reiterated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research report on Wednesday, September 4th. Robert W. Baird assumed coverage on CVS Health in a research report on Thursday, May 30th. They issued a “neutral” rating and a $61.00 price target on the stock. Finally, Barclays lowered their price target on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Eleven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.